BD today announced that Tom Polen will add the responsibility of chief operating officer of BD, in addition to his current role as president.
FRANKLIN LAKES, N.J., Oct. 3, 2018 /PRNewswire/ -- BD Medical (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Tom Polen will add the responsibility of chief operating officer of BD, in addition to his current role as president. Polen continues to report Vincent A. Forlenza, chairman and CEO. As president and chief operating officer, Polen will have oversight of BD’s three operating segments, its innovation and new product development pipeline, and global operations for the company, including all manufacturing facilities and supply chain operations. “Tom’s promotion reflects his leadership role developing and implementing BD’s strategy and vision and aligning our businesses under three strong segment leaders,” said Forlenza. “Tom’s priority of driving innovation to create category leadership, as well as his focus on integrating Bard and enhancing the customer experience, will help guide our segments, R&D portfolio and global operations as we continue to shape BD into a partner of choice for the global health care industry.” Polen was appointed president of BD in April 2017. The company has not had a chief operating officer role since 2016. About BD
View original content to download multimedia:http://www.prnewswire.com/news-releases/tom-polen-promoted-to-chief-operating-officer-of-bd-300723489.html SOURCE BD (Becton, Dickinson and Company) | ||||||||||||||||||||||||||||||||
Company Codes: NYSE:BDX |